The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Open accessAbstract
Atherosclerotic cardiovascular diseases (CVDs) are the biggest causes of death worldwide. In most people, CVD is the product of a number of causal risk factors. Several seemingly modest risk factors may, in combination, result in a much higher risk than an impressively raised single factor. For this reason, risk estimation systems have been developed to assist clinicians to assess the effects of risk factor combinations in planning management strategies. In this article, the performances of the major risk estimation systems are reviewed. Most perform usably well in populations that are similar to the one used to derive the system, and in other populations if calibrated to allow for different CVD mortality rates and different risk factor distributions. The effect of adding "new" risk factors to age, sex, smoking, lipid status, and blood pressure is usually small, but may help to appropriately reclassify some of those patients who are close to a treatment threshold to a more correct "treat/do not treat" category. Risk estimation in the young and old needs more research. Quantification of the hoped-for benefits of the multiple risk estimation approach in terms of improved outcomes is still needed. But, it is likely that the widespread use of such an approach will help to address the issues of both undertreatment and overtreatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most guidelines use one of these risk assessment systems [6-8].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [6]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used [6,8], can be used in any population regardless of baseline risk or secular changes in mortality, and therefore avoids the need for recalibration.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [6]
In the citing paper
“In practice, most risk estimation systems perform rather similarly when applied to populations recognizably similar to that from which the risk estimation system was derived, 6,7 and can be re-calibrated for use in different populations.6”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [6]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used, 51,52 which bypasses the dilemma of whether to use a risk estimation system based on CVD mortality or on the more attractive but less reliable endpoint of total CVD events.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
In the citing paper
“Most guidelines use one of these risk estimation systems. 50-52”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used, 51,52”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Flagged first, then by citations
1 of the 90 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- De Backer, 2003, Eur J Cardiovasc Prev Rehabil, 10, 1
- 1996, Matching the intensity of risk factor management with the hazard for coronary disease events, J Am Coll Cardiol, 27, 957
Cited by
Sorted by citations
Items 401–436 of 436
Sleep variability and cardiovascular health in undergraduate college students
Katulka, E. K. (2020) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/83me-az82
Cardiovascular Health in Professional Rugby Union Athletes
McHugh, C. (2021) · Arrow@dit (Dublin Institute of Technology)
Küçük, U., Duygu, A., & Gazı, E. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.864108
Sun, Z., Khan, A. H., & Tian, X. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1069
Erbel, R., Möhlenkamp, S., Moebus, S., Lehmann, N., & Jöckel, K. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.076
Sharma, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_6
Feng, X., Zhang, Y., Du, M., Li, S., Ding, J., Wang, J., Wang, Y., & Liu, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1533837/v1
Sun, Z., Khan, A. H., & Tian, X. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_1069-1
Total Cardiovascular Risk in the Elderly Population of Spain: The Epicardian Risk ScorePreprint
Gabriel, R., Muñiz, J., Vega, S., Moral, I., Lopez, I., Castro, T. R. P., Salvanés, F. R., Suárez, C., Novella, B., & Brotons, C. (2020) · doi:10.21203/rs.3.rs-33921/v1
Bioactive lipids in cardiovascular disease
Resende, C. X., Amador, A. F., Calvao, J., & Costa, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00001-4
Value of GRACE score in predicting benefit from invasive strategy in acute coronary syndrome patient
Esmail, A. M., Kabil, H., Tabl, M. A., & Hegab, A. Y. (2022) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2022.253645 · Cited by 1
Accelerated Atherosclerosis in SLE: Mechanisms, Consequences, and Future Directions
Semalulu, T., & Tselios, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105939
Efecto de la ingesta de polifenoles en biomarcadores y riesgo cardiovascular
García, M. R. (2022) · Buleria (Universidad de León) · doi:10.18002/10612/15968
Ullah, M., Hasan, M. M., Khalequzzaman, M., Islam, K. N., Rahman, M. M., & Easmin, T. (2023) · Cardiovascular Journal · doi:10.3329/cardio.v16i1.68206
SPECT MPI for Risk Assessment in Special Groups
Cuocolo, A., Zampella, E., Gaudieri, V., & Assante, R. (2024) · doi:10.1093/med/9780190095659.003.0014
Therapeutic Targeting of High-Density Lipoprotein Metabolism
deGoma, E. M., & Rader, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00044-x
Ranasinghe, S. U., Rathnadivakara, O. B. S. K., Ranasinghe, L. I., & Tennakoon, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4997260/v1
Kariuki, J. K., Ntim, M., & Gitonga, M. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-61160-5_14
Cardiovascular Risk Factors and Warning Signs
Escanor, R. A. N. (2023) · Scientific Journal Care & Tech · doi:10.69821/caretech.v1i1.6
Agreement Between Cardiovascular Risk Stratification Instruments in Geriatric Patients
Colombo, M. P. R., Ubiali, L. G., Keller, G. S., Grings, L. R., & Salvaro, R. G. (2025) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20230159
Pabin, A., Bojarczuk, A., Kade, G., Garbacz, A., Komar, K., & Maculewicz, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211109 · Cited by 3
Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union
Vikhireva, O. (2012) · UCL Discovery (University College London)
Additional file 1 of Suboptimal control status of young hypertensive population
Shin, D., Choi, J., & Lee, H.-Y. (2023) · Figshare · doi:10.6084/m9.figshare.22724235
How should we obtain a precise estimate of cardiovascular risk in asymptomatic adults?
Tasic, I. S., Kostić, S., Đorđević, D. B., Lovic, M., & Stojanović, N. (2020) · Srce i krvni sudovi · doi:10.5937/siks2011023t
Neto, A. T. D. M. F., Barroso, L. P., Fernandes, L. R., & O’Connell, J. L. (2026) · Cureus · doi:10.7759/cureus.104610
Paul, S., & Das, U. (2026) · International Conference on Electrical, Computer & Telecommunication Engineering (ICECTE) · doi:10.1109/icecte69292.2026.11429218
Pina, J., Santos, V., & Massuça, L. M. (2026) · Healthcare · doi:10.3390/healthcare14060751
Ươc tinh và phân tâng nguy cơ tim mạch trong phòng ngưa tiên phát
TRI, H. H. Q. (2021) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.97.2021.115
Thanh*, N. T. N., Trí, H. H. Q., Yersin, P. K. Đ. K., Minh*, T. H. C., & Minh, V. T. T. H. C. (2018) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.81.2018.1094
Tang, X., Tang, M., Liu, W., & Cui, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1849464
Quennelle, S., Malekzadeh-Milani, S. G., Garcelon, N., Burgun, A., Bonnet, D., & Neuraz, A. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06065-4
Liu, R., Arena, R. A., Santos‐de‐Araújo, A. D., Borghi‐Silva, A., & Popović, D. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103399
Bijkerk, S., Ponte-Negretti, C. I., Maung, K. K., Gnatiuc, L., Alegre-Díaz, J., Anderson, S. G., Claudia Bambs, S., Barreto, M. L., Bernabé‐Ortiz, A., Blankenberg, S., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag698 · Cited by 1
Mohammed, M., & Malki, A. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1866507
Jahan, N., Anjum, N., Chakravarty, S., Sterling, E. W., & Sakib, N. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-28463-1_22
Metadata
- Authors
- Cooney, M. T., Dudina, A. L., & Graham, I. M.
- Affiliations
- Tallaght University Hospital (IE)
- Corresponding author
- Graham, Ian M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 54
- Issue
- 14
- Pages
- 1209-1227
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W197402492
- Cited by
- 436
- References
- 90
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 28 · 2021: 28 · 2020: 28 · 2019: 27 · 2018: 28 · 2017: 20 · 2016: 38 · 2015: 34 · 2014: 28 · 2013: 24 · 2012: 26
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- cardiovascular risk assessment, atherosclerotic cardiovascular disease, risk factor combinations, calibration, undertreatment, overtreatment, young and elderly patients, cardiovascular mortality
- MeSH terms
- Age Factors, Cardiovascular Diseases, Humans, Models, Cardiovascular, Risk Factors, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
